Epinephrine/all

Synthesis[edit]

dopamine -> norepinephrine[edit]

DBH

	On chromosome	Chromosome position	In gene	Summary
rs1611114	9	133,635,081	DBH
rs1611115(T;T)	9	133,635,393	DBH	somewhat more associated with impulsiveness and adult ADHD
rs1611115	9	133,635,393	DBH
rs1611115(C;C)	9	133,635,393	DBH	normal
rs1611115(C;T)	9	133,635,393	DBH	normal
rs267606760(G;G)	9	133,636,672	DBH	common in clinvar
rs267606760	9	133,636,672	DBH
rs74853476	9	133,636,712	DBH
rs74853476(T;T)	9	133,636,712	DBH	common in clinvar
rs3025382	9	133,637,199	DBH
rs2007153(G;G)	9	133,638,697	DBH	increased risk of schizophrenia in limited study
rs2007153	9	133,638,697	DBH
rs2007153(A;A)	9	133,638,697	DBH	decreased risk of schizophrenia in limited study
rs2007153(A;G)	9	133,638,697	DBH	normal risk of schizophrenia in limited study
rs77576840(C;C)	9	133,639,848	DBH	common in clinvar
rs77576840	9	133,639,848	DBH
rs1108580	9	133,639,992	DBH
rs1108580(A;A)	9	133,639,992	DBH	common in clinvar
rs863225244	9	133,642,337	DBH
rs863225244(A;A)	9	133,642,337	DBH	common in clinvar
rs5320(G;G)	9	133,642,351	DBH	common in complete genomics
rs5320	9	133,642,351	DBH
rs863225245	9	133,643,474	DBH
rs863225245(G;G)	9	133,643,474	DBH	common in clinvar
rs1611125	9	133,644,190	DBH
rs4531(G;G)	9	133,644,248	DBH	common on affy axiom data
rs4531	9	133,644,248	DBH
rs2519152	9	133,644,512	DBH
rs267606761	9	133,647,854	DBH
rs267606761(G;G)	9	133,647,854	DBH	common in clinvar
rs75215331	9	133,647,906	DBH
rs75215331(C;C)	9	133,647,906	DBH	common in clinvar
rs2283123	9	133,650,175	DBH
rs2283123(C;C)	9	133,650,175	DBH	normal risk of schizophrenia in limited study
rs2283123(C;T)	9	133,650,175	DBH	decreased risk of schizophrenia in limited study
rs2283123(T;T)	9	133,650,175	DBH	decreased risk of schizophrenia in limited study
rs739398	9	133,651,448	DBH
rs77905(T;T)	9	133,652,975	DBH	common in clinvar
rs77905	9	133,652,975	DBH
rs6271(C;C)	9	133,657,152	DBH DBH-AS1	common in clinvar
rs6271	9	133,657,152	DBH DBH-AS1
rs863225246	9	133,657,174	DBH DBH-AS1
rs863225246(A;A)	9	133,657,174	DBH DBH-AS1	common in clinvar
rs129882	9	133,658,547	DBH DBH-AS1
rs129882(C;C)	9	133,658,547	DBH DBH-AS1	common in clinvar
rs761334309(C;C)	9	135,503,570	LOC101928525 MRPS2	common/normal
rs761334309(C;T)	9	135,503,570	LOC101928525 MRPS2	Carrier of a combined oxidative phosphorylation deficiency-36 mutation
rs761334309	9	135,503,570	LOC101928525 MRPS2
rs201229537	9	135,503,582	LOC101928525 MRPS2
rs758539748	9	135,503,655	LOC101928525 MRPS2

norepinephrine -> epinephrine[edit]

PNMT

	On chromosome	Chromosome position	In gene	Summary
rs773317399	17	39,666,015	TCAP PNMT
rs773317399(C;C)	17	39,666,015	TCAP PNMT	common in clinvar
rs149585781(G;G)	17	39,666,063	TCAP PNMT	common in clinvar
rs149585781	17	39,666,063	TCAP PNMT
rs3764351	17	39,668,086	PNMT

Degradation[edit]

norepinephrine[edit]

COMT

	On chromosome	Chromosome position	In gene	Summary
rs2075507	22	19,940,569	COMT TXNRD2
rs2097603	22	19,940,569	COMT TXNRD2
rs2020917	22	19,941,361	COMT TXNRD2
rs13306278	22	19,941,504	COMT TXNRD2
rs13306278(C;C)	22	19,941,504	COMT TXNRD2	common in clinvar
rs737866	22	19,942,586	COMT TXNRD2
rs737865(A;G)	22	19,942,598	COMT TXNRD2
rs737865	22	19,942,598	COMT TXNRD2
rs933271	22	19,943,884	COMT TXNRD2
rs5993882	22	19,950,010	COMT
rs3087869	22	19,953,984	COMT
rs740603	22	19,957,654	COMT
rs4646312	22	19,960,814	COMT
rs165656	22	19,961,340	COMT
rs165722	22	19,961,490	COMT
rs6269	22	19,962,429	COMT MIR4761
rs4633(C;T)	22	19,962,712	COMT MIR4761	higher risk for endometrial cancer
rs4633(C;C)	22	19,962,712	COMT MIR4761	normal
rs4633	22	19,962,712	COMT MIR4761
rs4633(T;T)	22	19,962,712	COMT MIR4761	higher risk for endometrial cancer
rs6267	22	19,962,740	COMT MIR4761
rs6267(G;G)	22	19,962,740	COMT MIR4761	common
rs6267(G;T)	22	19,962,740	COMT MIR4761	None
rs6267(T;T)	22	19,962,740	COMT MIR4761	None
rs740602	22	19,962,745	COMT MIR4761
rs740602(G;G)	22	19,962,745	COMT MIR4761	common in complete genomics
rs2239393	22	19,962,905	COMT MIR4761
rs4818(C;C)	22	19,963,684	COMT MIR4761	common in clinvar
rs4818(C;G)	22	19,963,684	COMT MIR4761
rs4818	22	19,963,684	COMT MIR4761
rs8192488	22	19,963,714	COMT MIR4761
rs8192488(C;C)	22	19,963,714	COMT MIR4761	common in complete genomics
rs4680(A;A)	22	19,963,748	COMT MIR4761	(worrier) advantage in memory and attention tasks
rs4680(A;G)	22	19,963,748	COMT MIR4761	Intermediate dopamine levels, other effects
rs165688(G;G)	22	19,963,748	COMT MIR4761
rs4680	22	19,963,748	COMT MIR4761	warrior vs worrier; number of other associations
rs165688	22	19,963,748	COMT MIR4761
rs17849308	22	19,963,748	COMT MIR4761
rs4680(G;G)	22	19,963,748	COMT MIR4761	(warrior) multiple associations, see details
rs769224(G;G)	22	19,964,281	COMT MIR4761
rs769224	22	19,964,281	COMT MIR4761
rs165631	22	19,964,293	COMT MIR4761
rs165631(C;C)	22	19,964,293	COMT MIR4761	common/normal
rs165631(C;T)	22	19,964,293	COMT MIR4761	Perhaps slightly lower risk for breast cancer in BRCA1/2 mutation carriers?
rs4646316	22	19,964,609	COMT
rs165774	22	19,965,038	COMT
rs9332377	22	19,968,169	COMT ARVCF
rs9332377(C;C)	22	19,968,169	COMT ARVCF	common/normal
rs165599(A;G)	22	19,969,258	COMT ARVCF
rs165599(A;A)	22	19,969,258	COMT ARVCF
... further results

MAOA

	On chromosome	Chromosome position	In gene	Summary
rs5953210	X	43,654,798	MAOA
rs3788862	X	43,658,116	MAOA
rs5906883	X	43,667,695	MAOA
rs1465107	X	43,678,769	MAOA
rs796065312(C;C)	X	43,683,572	MAOA	common in clinvar
rs796065312	X	43,683,572	MAOA
rs5906957	X	43,688,062	MAOA
rs909525(A;A)	X	43,693,955	MAOA	Probably MAOA 4 or 5 repeats: not Warrior Gene.
rs909525(G;G)	X	43,693,955	MAOA	Perhaps MAOA 3 repeats: Warrior Gene?
rs909525(A;G)	X	43,693,955	MAOA	Probably one Warrior Gene and one non-Warrior Gene.
rs909525	X	43,693,955	MAOA	Best proxy for Warrior Gene repeats.
rs2283725	X	43,700,729	MAOA
rs796065311	X	43,731,344	MAOA
rs796065311(-;-)	X	43,731,344	MAOA	common in clinvar
rs587777457	X	43,731,695	MAOA
rs587777457(G;G)	X	43,731,695	MAOA	common in clinvar
rs72554632(T;T)	X	43,731,784	MAOA	possible mental retardation
rs72554632(C;T)	X	43,731,784	MAOA	Carrier for Brunner's Syndrome
rs72554632	X	43,731,784	MAOA
rs72554632(C;C)	X	43,731,784	MAOA	common in clinvar
rs6323(T;T)	X	43,731,789	MAOA	reduced MAOA activity
rs6323	X	43,731,789	MAOA	Monoamine oxidase A activity
rs6323(G;G)	X	43,731,789	MAOA	Increased monoamine oxidase A activity
rs3027400	X	43,733,516	MAOA
rs2235186	X	43,736,181	MAOA
rs2072743	X	43,740,274	MAOA
rs979606	X	43,741,895	MAOA
rs1137070	X	43,744,144	MAOA
rs3027407	X	43,745,594	MAOA
rs3027409	X	43,747,786	MAOA
rs3027409(T;T)	X	43,747,786	MAOA	common on affy axiom data
rs6609257	X	43,753,461	MAOA

PNMT (conversion to epinephrine)

	On chromosome	Chromosome position	In gene	Summary
rs773317399	17	39,666,015	TCAP PNMT
rs773317399(C;C)	17	39,666,015	TCAP PNMT	common in clinvar
rs149585781	17	39,666,063	TCAP PNMT
rs149585781(G;G)	17	39,666,063	TCAP PNMT	common in clinvar
rs3764351	17	39,668,086	PNMT

epinephrine[edit]

COMT

	On chromosome	Chromosome position	In gene	Summary
rs2097603	22	19,940,569	COMT TXNRD2
rs2075507	22	19,940,569	COMT TXNRD2
rs2020917	22	19,941,361	COMT TXNRD2
rs13306278	22	19,941,504	COMT TXNRD2
rs13306278(C;C)	22	19,941,504	COMT TXNRD2	common in clinvar
rs737866	22	19,942,586	COMT TXNRD2
rs737865	22	19,942,598	COMT TXNRD2
rs737865(A;G)	22	19,942,598	COMT TXNRD2
rs933271	22	19,943,884	COMT TXNRD2
rs5993882	22	19,950,010	COMT
rs3087869	22	19,953,984	COMT
rs740603	22	19,957,654	COMT
rs4646312	22	19,960,814	COMT
rs165656	22	19,961,340	COMT
rs165722	22	19,961,490	COMT
rs6269	22	19,962,429	COMT MIR4761
rs4633(C;T)	22	19,962,712	COMT MIR4761	higher risk for endometrial cancer
rs4633(C;C)	22	19,962,712	COMT MIR4761	normal
rs4633	22	19,962,712	COMT MIR4761
rs4633(T;T)	22	19,962,712	COMT MIR4761	higher risk for endometrial cancer
rs6267(G;G)	22	19,962,740	COMT MIR4761	common
rs6267(G;T)	22	19,962,740	COMT MIR4761	None
rs6267(T;T)	22	19,962,740	COMT MIR4761	None
rs6267	22	19,962,740	COMT MIR4761
rs740602(G;G)	22	19,962,745	COMT MIR4761	common in complete genomics
rs740602	22	19,962,745	COMT MIR4761
rs2239393	22	19,962,905	COMT MIR4761
rs4818(C;G)	22	19,963,684	COMT MIR4761
rs4818	22	19,963,684	COMT MIR4761
rs4818(C;C)	22	19,963,684	COMT MIR4761	common in clinvar
rs8192488(C;C)	22	19,963,714	COMT MIR4761	common in complete genomics
rs8192488	22	19,963,714	COMT MIR4761
rs165688(G;G)	22	19,963,748	COMT MIR4761
rs4680	22	19,963,748	COMT MIR4761	warrior vs worrier; number of other associations
rs165688	22	19,963,748	COMT MIR4761
rs17849308	22	19,963,748	COMT MIR4761
rs4680(G;G)	22	19,963,748	COMT MIR4761	(warrior) multiple associations, see details
rs4680(A;A)	22	19,963,748	COMT MIR4761	(worrier) advantage in memory and attention tasks
rs4680(A;G)	22	19,963,748	COMT MIR4761	Intermediate dopamine levels, other effects
rs769224(G;G)	22	19,964,281	COMT MIR4761
rs769224	22	19,964,281	COMT MIR4761
rs165631	22	19,964,293	COMT MIR4761
rs165631(C;C)	22	19,964,293	COMT MIR4761	common/normal
rs165631(C;T)	22	19,964,293	COMT MIR4761	Perhaps slightly lower risk for breast cancer in BRCA1/2 mutation carriers?
rs4646316	22	19,964,609	COMT
rs165774	22	19,965,038	COMT
rs9332377	22	19,968,169	COMT ARVCF
rs9332377(C;C)	22	19,968,169	COMT ARVCF	common/normal
rs165599(A;A)	22	19,969,258	COMT ARVCF
rs165599	22	19,969,258	COMT ARVCF
... further results

Transporters[edit]

norepinephrine[edit]

SLC6A2/NET

	On chromosome	Chromosome position	In gene	Summary
rs3751723	16	54,286,285	IRX3
rs2397771	16	55,655,175	SLC6A2
rs168924	16	55,655,632	SLC6A2
rs2242446	16	55,656,513	SLC6A2
rs2242446(C;C)	16	55,656,513	SLC6A2	common in clinvar
rs3785143	16	55,661,194	SLC6A2
rs3785143(C;T)	16	55,661,194	SLC6A2	may be associated with ADHD
rs3785143(C;C)	16	55,661,194	SLC6A2	normal risk of ADHD
rs3785143(T;T)	16	55,661,194	SLC6A2	may be associated with ADHD
rs36029	16	55,662,844	SLC6A2
rs1532701	16	55,664,115	SLC6A2
rs192303	16	55,666,312	SLC6A2
rs734980(A;A)	16	55,668,637	SLC6A2	common in complete genomics
rs734980	16	55,668,637	SLC6A2
rs187715	16	55,670,130	SLC6A2
rs187715(A;A)	16	55,670,130	SLC6A2
rs36020	16	55,679,176	SLC6A2
rs3785152(C;C)	16	55,682,638	SLC6A2	common in complete genomics
rs3785152	16	55,682,638	SLC6A2
rs40147	16	55,682,928	SLC6A2
rs36017	16	55,684,906	SLC6A2
rs10521329	16	55,686,546	SLC6A2
rs3785155	16	55,688,478	SLC6A2
rs3785155(G;G)	16	55,688,478	SLC6A2
rs4436775	16	55,690,444	SLC6A2
rs4564560	16	55,690,852	SLC6A2
rs11568324(C;C)	16	55,692,146	SLC6A2	common in complete genomics
rs11568324	16	55,692,146	SLC6A2
rs1861647	16	55,694,494	SLC6A2
rs3785157	16	55,695,924	SLC6A2
rs5568(A;A)	16	55,696,212	SLC6A2	common in clinvar
rs5568	16	55,696,212	SLC6A2
rs1566652	16	55,697,663	SLC6A2
rs5569	16	55,697,923	SLC6A2
rs5569(C;C)	16	55,697,923	SLC6A2	common in clinvar
rs121918126	16	55,698,005	SLC6A2
rs121918126(G;G)	16	55,698,005	SLC6A2	common in clinvar
rs998424	16	55,698,034	SLC6A2
rs998424(C;C)	16	55,698,034	SLC6A2	common in clinvar
rs1805067	16	55,698,511	SLC6A2
rs36009	16	55,698,708	SLC6A2
rs5558(G;G)	16	55,699,647	SLC6A2	None
rs5558	16	55,699,647	SLC6A2
rs5558(A;A)	16	55,699,647	SLC6A2
rs5558(T;T)	16	55,699,647	SLC6A2	normal
rs5558(T;G)	16	55,699,647	SLC6A2	None
rs1800887	16	55,699,677	SLC6A2
rs8049681	16	55,701,438	SLC6A2
rs2242447	16	55,702,000	SLC6A2
rs7194256	16	55,703,779	SLC6A2
... further results

SLC18A2/VMAT2

	On chromosome	Chromosome position	In gene	Summary
rs60912143	10	117,241,017	SLC18A2 LOC105378500
rs363387	10	117,244,053	SLC18A2 LOC105378500
rs363387(T;T)	10	117,244,053	SLC18A2 LOC105378500
rs1060499741	10	117,255,281	SLC18A2
rs1060499741(C;C)	10	117,255,281	SLC18A2	common in clinvar
rs2015586	10	117,262,226	SLC18A2
rs363224	10	117,263,062	SLC18A2
rs363224(A;A)	10	117,263,062	SLC18A2	Protective against TD occurrence
rs363227	10	117,267,055	SLC18A2
rs363276	10	117,274,298	SLC18A2

epinephrine[edit]

Adrenergic receptors[edit]

alpha1[edit]

ADRA1A

	On chromosome	Chromosome position	In gene
rs3802241	8	26,765,867	ADRA1A
rs1048101	8	26,770,511	ADRA1A
rs13278849	8	26,857,357	ADRA1A
rs17426222	8	26,860,300	ADRA1A
rs4732957	8	26,861,363	ADRA1A
rs4732682	8	26,863,376	ADRA1A
rs573514	8	26,863,764	ADRA1A
rs2229125	8	26,864,371	ADRA1A
rs1383914	8	26,865,532	ADRA1A
rs574584	8	26,866,167	ADRA1A
rs573542	8	26,866,301	ADRA1A
rs3808585	8	26,866,809	ADRA1A

ADRA1B

	On chromosome	Chromosome position	In gene	Summary
rs2082412	5	159,290,781
rs3181224(T;T)	5	159,313,842	LOC105377683
rs3181224	5	159,313,842	LOC105377683
rs1368439	5	159,315,006	LOC105377683 IL12B
rs1368439(G;G)	5	159,315,006	LOC105377683 IL12B	common in clinvar
rs3212227(A;C)	5	159,315,942	IL12B	Significantly increased risk of developing cervical cancer
rs3212227(C;C)	5	159,315,942	IL12B	Significantly increased risk of developing cervical cancer
rs3212227	5	159,315,942	IL12B
rs3212227(A;A)	5	159,315,942	IL12B	1.43x increased risk of developing psoriasis and psoriatic arthritis
rs3213120	5	159,316,100	IL12B
rs3213120(G;G)	5	159,316,100	IL12B	common in complete genomics
rs3213119	5	159,316,780	IL12B
rs3213119(C;C)	5	159,316,780	IL12B
rs3213119(G;G)	5	159,316,780	IL12B	common in complete genomics
rs11574790	5	159,316,838	IL12B
rs919766	5	159,320,556	LOC107986469 IL12B
rs2853694	5	159,322,080	LOC107986469 IL12B
rs2288831	5	159,323,005	LOC107986469 IL12B
rs587776807	5	159,323,098	LOC107986469 IL12B
rs587776807(-;-)	5	159,323,098	LOC107986469 IL12B	common in clinvar
rs786201006	5	159,323,113	LOC107986469 IL12B
rs786201006(TCGCTCCT;TCGCTCCT)	5	159,323,113	LOC107986469 IL12B	common in clinvar
rs3213094(A;A)	5	159,323,761	LOC107986469 IL12B	0.79x risk for psoriasis
rs3213094	5	159,323,761	LOC107986469 IL12B
rs3213094(G;G)	5	159,323,761	LOC107986469 IL12B
rs3213094(A;G)	5	159,323,761	LOC107986469 IL12B	0.79x risk for psoriasis
rs3212220	5	159,327,187	LOC107986469 IL12B
rs3212217	5	159,328,122	IL12B
rs1003199	5	159,328,558	IL12B
rs2546893	5	159,328,952	IL12B
rs2546890	5	159,332,892	LOC285626	Associated with multiple sclerosis
rs2546890(A;A)	5	159,332,892	LOC285626	Higher risk of multiple sclerosis
rs2546890(A;G)	5	159,332,892	LOC285626	Higher risk of multiple sclerosis
rs2546890(G;G)	5	159,332,892	LOC285626	Lower risk of multiple sclerosis
rs17860508	5	159,333,192	LOC285626
rs41292470	5	159,333,192	AC008697.1
rs2030373	5	159,920,474	ADRA1B
rs6884105	5	159,921,436	ADRA1B
rs756275	5	159,924,453	ADRA1B
rs6892282	5	159,933,478	ADRA1B
rs10515807	5	159,937,991	ADRA1B LOC101927790
rs6888306	5	159,940,107	ADRA1B LOC101927790
rs13162302	5	159,940,268	ADRA1B LOC101927790
rs11750092	5	159,940,964	ADRA1B LOC101927790

ADRA1D

	On chromosome	Chromosome position	In gene	Summary
rs2236554	20	4,221,394	ADRA1D
rs1556832	20	4,234,910	ADRA1D

alpha2[edit]

ADRA2A

	On chromosome	Chromosome position	In gene	Summary
rs521674	10	111,075,832	ADRA2A
rs1800544	10	111,076,745	ADRA2A
rs1800545	10	111,077,780	ADRA2A
rs11195419(C;C)	10	111,079,610	ADRA2A	common in complete genomics
rs11195419	10	111,079,610	ADRA2A
rs553668(C;C)	10	111,079,821	ADRA2A	common/normal
rs553668(T;T)	10	111,079,821	ADRA2A
rs553668	10	111,079,821	ADRA2A

ADRA2B

	On chromosome	Chromosome position	In gene	Summary
rs2229169(A;A)	2	96,114,968	ADRA2B	1.5x increased risk of heart attack and stroke but better emotional memory and stop-go performance
rs2229169(C;C)	2	96,114,968	ADRA2B	1.5x decreased risk of heart attack and stroke but worse emotional memory and stop-go performance
rs2229169	2	96,114,968	ADRA2B	Good proxy for ADRA2B del301–303
rs28365031	2	96,115,249	ADRA2B
rs29000568	2	96,115,256	ADRA2B
rs29000568(AGAGGAGGA;AGAGGAGGA)	2	96,115,256	ADRA2B	common/normal
rs4066772	2	96,115,258	ADRA2B
rs879255577	2	96,115,464	ADRA2B
rs786205528	2	96,115,486	ADRA2B
rs786205528(C;C)	2	96,115,486	ADRA2B	common in clinvar
rs1724120	2	96,143,592	ASTL DUSP2

ADRA2C

	On chromosome	Chromosome position	In gene	Summary
rs2229169(A;A)	2	96,114,968	ADRA2B	1.5x increased risk of heart attack and stroke but better emotional memory and stop-go performance
rs2229169(C;C)	2	96,114,968	ADRA2B	1.5x decreased risk of heart attack and stroke but worse emotional memory and stop-go performance
rs2229169	2	96,114,968	ADRA2B	Good proxy for ADRA2B del301–303
rs28365031	2	96,115,249	ADRA2B
rs29000568	2	96,115,256	ADRA2B
rs29000568(AGAGGAGGA;AGAGGAGGA)	2	96,115,256	ADRA2B	common/normal
rs4066772	2	96,115,258	ADRA2B
rs879255577	2	96,115,464	ADRA2B
rs786205528	2	96,115,486	ADRA2B
rs786205528(C;C)	2	96,115,486	ADRA2B	common in clinvar

beta1[edit]

ADRB1

	On chromosome	Chromosome position	In gene	Summary
rs1801252	10	114,044,277	ADRB1
rs1801252(A;A)	10	114,044,277	ADRB1	None
rs1801252(G;G)	10	114,044,277	ADRB1
rs1801252(A;G)	10	114,044,277	ADRB1
rs1801253	10	114,045,297	ADRB1
rs1801253(G;G)	10	114,045,297	ADRB1
rs1801253(C;C)	10	114,045,297	ADRB1	responds well to bucindolol; may also depend on rs1801252
rs1801253(C;G)	10	114,045,297	ADRB1

beta2[edit]

ADRB2

	On chromosome	Chromosome position	In gene	Summary
rs17778257	5	148,825,014	ADRB2
rs34623097	5	148,825,046	ADRB2
rs2895795	5	148,825,403	ADRB2
rs2400707	5	148,825,489	ADRB2
rs2053044	5	148,825,809	ADRB2
rs17108803	5	148,825,993	ADRB2
rs12654778	5	148,826,178	ADRB2
rs11168070	5	148,826,364	ADRB2
rs11959427	5	148,826,465	ADRB2
rs1042711	5	148,826,785	ADRB2
rs1801704	5	148,826,812	ADRB2
rs17334242(A;A)	5	148,826,877	ADRB2
rs1042713(G;G)	5	148,826,877	ADRB2	normal
rs1042713(A;A)	5	148,826,877	ADRB2	1.7x increased risk that pediatric inhaler use may make asthma worse
rs17334242	5	148,826,877	ADRB2
rs1042713(A;G)	5	148,826,877	ADRB2	1.3x increased risk that pediatric inhaler use may make asthma worse
rs1042713	5	148,826,877	ADRB2
rs1042714	5	148,826,910	ADRB2
rs1042714(G;G)	5	148,826,910	ADRB2	complex; see details for increased risks
rs1042714(C;G)	5	148,826,910	ADRB2	complex; see details for increased risks
rs1042714(C;C)	5	148,826,910	ADRB2	normal
rs1042717	5	148,827,083	ADRB2
rs1800888(T;T)	5	148,827,322	ADRB2	increased risk of coronary artery disease
rs1800888(C;T)	5	148,827,322	ADRB2	increased risk of coronary artery disease
rs1800888	5	148,827,322	ADRB2
rs1800888(C;C)	5	148,827,322	ADRB2	normal
rs1042718	5	148,827,354	ADRB2
rs1042719	5	148,827,884	ADRB2

beta3[edit]

ADRB3

	On chromosome	Chromosome position	In gene	Summary
rs4994(C;T)	8	37,966,280	ADRB3	2x higher risk in certain women for cardiac events; associated with elite endurance performance in men
rs4994	8	37,966,280	ADRB3
rs4994(T;T)	8	37,966,280	ADRB3	normal
rs4994(C;C)	8	37,966,280	ADRB3	2x higher risk in certain women for cardiac events; associated with elite endurance performance in men

Epinephrine/all

Contents

Synthesis[edit]

dopamine -> norepinephrine[edit]

norepinephrine -> epinephrine[edit]

Degradation[edit]

norepinephrine[edit]

epinephrine[edit]

Transporters[edit]

norepinephrine[edit]

epinephrine[edit]

Adrenergic receptors[edit]

alpha1[edit]

alpha2[edit]

beta1[edit]

beta2[edit]

beta3[edit]